Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

Poster: The use of fragment ion and collision cross section for confident identification from LC-ION mobility-MS metabolomics data (Waters Corporation)

7 Oct 2014
General interest

A novel and confident identification of metabolomics and lipidomics UPLC-ion mobility MS datasets
bases on fragment ion and collision cross section.


Click here to view poster

Related Links

  • Waters Corporation

 

Top content

  • Driving innovation in clinical research: a look inside Worldwide’s large molecule lab
  • Thermo Fisher’s NGS assay receives FDA approval
  • Major M&A deals impacting bioanalysis in 2025

Related tags

LC metabolomics MS
Previous article Next article

Related articles

28 MAR 2017 ASK THE EXPERTS
Ask the Experts: Dajana Vuckovic
26 SEP 2016 CHROMATOGRAPHY
Advances in LC: bioanalytical method transfer
31 OCT 2010 CLINICAL
Are meaningful predictions of toxicological outcomes in clinical trials based on in vitro diagnostics of preclinical drug candidates possible?
25 MAR 2011 CHROMATOGRAPHY
Symposium Report: The Waters Bioanalysis World Tour: The Broadening Impact and Future of the DMPK Laboratory – Addressing Large-Molecule Therapeutics
6 FEB 2014 GENERAL INTEREST
Global metabolic profiling for the study of alcohol-related disorders
22 AUG 2014 INTERVIEWS
Interview with Erin Chambers (Waters Corporation) on the ionKey/MS system
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone